logo
RFK Jr.'s plans for preventive health panel spark "deep concerns" from medical association

RFK Jr.'s plans for preventive health panel spark "deep concerns" from medical association

CBS News28-07-2025
The American Medical Association is expressing "deep concern" after a report that Health and Human Services Secretary Robert F. Kennedy may be planning to remove all members of the U.S. Preventive Services Task Force.
The task force, also known as the USPSTF, is a panel of independent medical experts whose recommendations help guide insurance companies and doctors' decisions about a range of preventive health measures, like cancer and diabetes screenings as well as HIV and cholesterol drugs.
In a letter posted on Sunday, the AMA — the largest association of physicians in the U.S. — addressed Kennedy over a report published Friday in The Wall Street Journal. The WSJ story cited sources familiar with the matter as saying Kennedy plans to dismiss the task force members because he views them as too "woke."
"USPSTF plays a critical, non-partisan role in guiding physicians' efforts to prevent disease and improve the health of patients by helping to ensure access to evidence-based clinical preventive services," the AMA's letter said. "As such, we urge you to retain the previously appointed members of the USPSTF and commit to the long-standing process of regular meetings to ensure their important work can continue without interruption."
In a statement to CBS News Friday, an HHS spokesperson said, "No final decision has been made on how the USPSTF can better support HHS' mandate to Make America Healthy Again."
on how the USPSTF can better support HHS' mandate to Make America Healthy Again."
The task force was created more than 40 years ago, but its work took on added significance after passage of the Affordable Care Act in 2010. The law requires health insurers and group health plans to provide preventive services that are recommended by the task force without imposing co-pays, deductibles or other cost-sharing charges on patients.
In June, the U.S. Supreme Court upheld the structure of the task force, but ruled that its members are "inferior officers" that can be "removable at will" by the HHS secretary. As the case played out, nonprofit organizations warned the Supreme Court that eliminating cost-sharing for services like breast cancer screenings or HIV-prevention medications would dissuade patients from seeking medical care.
Last month, Kennedy fired all 17 members of the Advisory Committee for Immunization Practice, also known as ACIP, a separate government panel of that makes vaccine recommendations. He later named eight new advisers, including several allies he has worked with closely over the years and some members with a history as vaccine critics.
Read the AMA's full letter below:
Read the AMA's full letter below:Melissa Quinn
contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

11-year-old boy bravely fighting cancer throws first pitch at Fenway Park
11-year-old boy bravely fighting cancer throws first pitch at Fenway Park

CBS News

time2 minutes ago

  • CBS News

11-year-old boy bravely fighting cancer throws first pitch at Fenway Park

The Boston Red Sox celebrated an 11-year-old boy who is bravely fighting cancer. Max Acuto has gone from isolation in the ICU, to roaring applause filling Fenway Park. "There were so many times we were stuck in the house or the hospital because his counts were low, and we couldn't be surrounded by people. I'm just so happy to be here and have him have this experience," said Courtney Acuto, of her son. Max Acuto, throwing the first pitch Tuesday night, felt like a dream come true for the Princeton family living a nightmare. Their 9-year-old was diagnosed with T-cell acute lymphoblastic leukemia in 2023. Now 11, he's been so brave; a source of inspiration for the WPI baseball team, who have become his supporters and friends thanks to Team Impact. "I play a lot of baseball. I've been practicing a lot. It was really cool. Being on that field and how many people there were," Max said. Cheering Max on the mound is a moment of joy for this family after they have endured so much. But the true celebration comes this December when the sixth grader completes two years of grueling treatment. "Two out of three weeks he's getting chemotherapy. With the procedures he has to get, oral chemo at home, going in every Wednesday for treatment in clinic," said his dad Bryan Acuto. "I remember them telling us it was going to be two full years of chemo. I was like how do we even get there? He is so resilient; So easy going, always has a smile. Honestly he got us through our hardest days," Courtney added. After showing such quiet courage through the hard times, these good times... never seemed so good. "It's hard to imagine at the beginning of treatment we'd be here, and getting his strength back. Being able to watch that - the strength and perseverance he's shown has been really wonderful. The strength Max possesses I didn't know existed," Bryan said.

BeautyHealth (SKIN) To Report Earnings Tomorrow: Here Is What To Expect
BeautyHealth (SKIN) To Report Earnings Tomorrow: Here Is What To Expect

Yahoo

time30 minutes ago

  • Yahoo

BeautyHealth (SKIN) To Report Earnings Tomorrow: Here Is What To Expect

Skincare company BeautyHealth (NASDAQ:SKIN) will be announcing earnings results this Thursday after the bell. Here's what to look for. BeautyHealth beat analysts' revenue expectations by 8.9% last quarter, reporting revenues of $69.58 million, down 14.5% year on year. It was a very strong quarter for the company, with an impressive beat of analysts' gross margin estimates and a solid beat of analysts' EBITDA estimates. Is BeautyHealth a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting BeautyHealth's revenue to decline 17.5% year on year to $74.74 million, improving from the 22.9% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.02 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. BeautyHealth has missed Wall Street's revenue estimates twice over the last two years. Looking at BeautyHealth's peers in the personal care segment, some have already reported their Q2 results, giving us a hint as to what we can expect. USANA delivered year-on-year revenue growth of 10.8%, beating analysts' expectations by 4.7%, and Nature's Sunshine reported revenues up 3.8%, topping estimates by 2.2%. USANA traded up 12.4% following the results while Nature's Sunshine was also up 13.7%. Read our full analysis of USANA's results here and Nature's Sunshine's results here. Investors in the personal care segment have had fairly steady hands going into earnings, with share prices down 1.9% on average over the last month. BeautyHealth is down 25.9% during the same time and is heading into earnings with an average analyst price target of $1.66 (compared to the current share price of $1.63). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store